Funamizu, N.; Honjo, M.; Tamura, K.; Sakamoto, K.; Ogawa, K.; Takada, Y.
microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer. Cancers 2023, 15, 1230.
https://doi.org/10.3390/cancers15041230
AMA Style
Funamizu N, Honjo M, Tamura K, Sakamoto K, Ogawa K, Takada Y.
microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer. Cancers. 2023; 15(4):1230.
https://doi.org/10.3390/cancers15041230
Chicago/Turabian Style
Funamizu, Naotake, Masahiko Honjo, Kei Tamura, Katsunori Sakamoto, Kohei Ogawa, and Yasutsugu Takada.
2023. "microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer" Cancers 15, no. 4: 1230.
https://doi.org/10.3390/cancers15041230
APA Style
Funamizu, N., Honjo, M., Tamura, K., Sakamoto, K., Ogawa, K., & Takada, Y.
(2023). microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer. Cancers, 15(4), 1230.
https://doi.org/10.3390/cancers15041230